# SAM #36C26027Q0117

VA molecular diagnostic system and infectious-disease testing panels for Boise VAMC

**Buyer:** Vanco 20
**Posted:** November 09, 2026
**Respond By:** November 28, 2026
**Identifier:** 36C26027Q0117
**NAICS:** 325413, 423450

The Department of Veterans Affairs is seeking a molecular diagnostic testing system and infectious-disease panel reagents for Boise VA Medical Center.
- **Government buyer:** Department of Veterans Affairs, Network Contract Office 20; Boise VA Medical Center.
- **Requested system:** A high-throughput, FDA-approved molecular diagnostic system for rapid syndromic infectious-disease testing; no model or system quantity is stated.
- **Panel quantities:** The listed annual quantities apply to the base period and each of four option periods:
  - Blood Culture Panel: 154 per year; 770 across five periods.
  - COVID 19 Diagnostic Panel: 626 per year; 3,130 across five periods.
  - Gastrointestinal PCR Panel: 409 per year; 2,045 across five periods.
  - Meningitis Encephalitis Panel: 16 per year; 80 across five periods.
  - Pneumonia Bal PCR Panel: 99 per year; 495 across five periods.
- **OEMs and vendors:** No manufacturer, OEM, or vendor is identified in the provided materials. No part numbers are provided.
- **Notable requirement:** The system and panels are intended to support rapid syndromic infectious-disease diagnostics. The acquisition is described as a rental purchase agreement, with additional products potentially ordered as needed.

### Description

<p>Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement.&nbsp; Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels.&nbsp;</p>

[View original listing](https://sam.gov/opp/b6d17aea5ceb4b8d988004142043a40b/view)